DOXORUBICIN for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where DOXORUBICIN was used for Prostate cancer.
Most Reported Side Effects for DOXORUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 8,844 | 10.7% | 1,075 | 5,491 |
| Off label use | 7,858 | 9.5% | 1,712 | 2,385 |
| Disease progression | 6,165 | 7.5% | 1,384 | 865 |
| Neutropenia | 5,891 | 7.1% | 927 | 2,104 |
| Drug ineffective | 4,598 | 5.6% | 1,342 | 1,068 |
| Pyrexia | 3,697 | 4.5% | 482 | 2,503 |
| Thrombocytopenia | 3,638 | 4.4% | 645 | 1,330 |
| Anaemia | 3,601 | 4.4% | 555 | 1,566 |
| Product use in unapproved indication | 3,502 | 4.2% | 821 | 978 |
| Nausea | 2,925 | 3.5% | 279 | 1,405 |
| Sepsis | 2,740 | 3.3% | 1,481 | 1,198 |
| Pneumonia | 2,611 | 3.2% | 839 | 1,521 |
| Death | 2,515 | 3.0% | 2,514 | 299 |
| Diarrhoea | 2,330 | 2.8% | 403 | 1,216 |
| Vomiting | 2,279 | 2.8% | 310 | 1,233 |
Other Indications for DOXORUBICIN
Diffuse large b-cell lymphoma (15,213)
Product used for unknown indication (5,186)
Hodgkin's disease (4,606)
B-cell lymphoma (3,947)
Breast cancer (3,641)
Non-hodgkin's lymphoma (3,298)
Acute lymphocytic leukaemia (3,128)
Plasma cell myeloma (2,820)
Chemotherapy (1,756)
Ovarian cancer (1,692)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)